Pirenperone
Top View
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- A Drug Discrimination Analysis of Lysergic Acid Diethylamide (LSD
- List of Common Prohibited Substance for the California Equine Medication
- Discriminative Stimulus Effects of 3,4-Methylenedioxypyrovalerone (MDPV) and Structurally Related Synthetic Cathinones
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
- Pharmaabkommen A1 E
- Serotonergic-Dopaminergic Mediation of -Ties Yof 3 4-Methylenedioxymethamphetamine Mid Nistre (MDMA, "Ecstasy") Ail T of )F a MARTIND
- Example List of Forbidden Substances
- Customs Tariff - Schedule Xxi - 1
- Wo 2007/044693 A2
- Multi-Parametric Profiling of Endothelial Cell Networks Reveals Functional Role of Glutamate Receptors in Angiogenesis
- Drugs and Medications
- The Behavioral Pharmacology of Hallucinogens William E
- A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
- 2020 AQHA Guidelines and Rules for Drugs and Medications
- Known Bioactives Library: Prestwick 2 Collection
- Sleep Apnea and CMV Driver Safety
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances